{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:52:47Z","timestamp":1786600367129,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1136\/ard.2011.153817","type":"journal-article","created":{"date-parts":[[2011,9,8]],"date-time":"2011-09-08T03:34:02Z","timestamp":1315452842000},"page":"61-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case\u2013control study"],"prefix":"10.1016","volume":"71","author":[{"given":"Maria Angeles","family":"Martinez-Zamora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Creus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Tassies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Reverter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Balasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2011.153817_bib1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.153817_bib2","first-page":"135","article-title":"Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials","volume":"99","author":"Empson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ard.2011.153817_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00001703-200306000-00010","article-title":"Is miscarriage a coagulopathy?","volume":"15","author":"Rai","year":"2003","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1136\/ard.2011.153817_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/jaut.2000.0421","article-title":"Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies","volume":"15","author":"Khamashta","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2011.153817_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2007.11.014","article-title":"Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity","volume":"30","author":"Meroni","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2011.153817_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.autrev.2008.08.001","article-title":"Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies","volume":"7","author":"Meroni","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2011.153817_bib7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/ard.2007.083873","article-title":"Antiphospholipid syndrome dilemmas still to be solved: 2008 status","volume":"67","author":"Shoenfeld","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2011.153817_bib8","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C","article-title":"High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin","volume":"44","author":"Erkan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.153817_bib9","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/art.10165","article-title":"Thromboembolic events after fetal loss in patients with antiphospholipid syndrome: comment on the article by Erkan","volume":"46","author":"Tincani","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.153817_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/deh844","article-title":"Recurrent miscarriage and long-term thrombosis risk: a case\u2013control study","volume":"20","author":"Quenby","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1136\/ard.2011.153817_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1136\/ard.2011.153817_bib12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.2011.153817_bib13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlb\u00e4ck","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard.2011.153817_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.fertnstert.2003.09.042","article-title":"Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening","volume":"81","author":"F\u00e1bregues","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1136\/ard.2011.153817_bib15","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1136\/ard.2011.153817_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0049-3848(77)90208-0","article-title":"Antithrombin (heparin cofactor) assay with \u201cnew\u201d chromogenic substrates (S-2238 and Chromozym TH)","volume":"11","author":"Abildgaard","year":"1977","journal-title":"Thromb Res"},{"key":"10.1136\/ard.2011.153817_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1660995","article-title":"The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency","volume":"51","author":"Bertina","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.2011.153817_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00001721-199404000-00004","article-title":"New direct assay of free protein S antigen using two distinct monoclonal antibodies specific for the free form","volume":"5","author":"Amiral","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1136\/ard.2011.153817_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/humupd\/5.6.707","article-title":"The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect","volume":"5","author":"Lewis","year":"1999","journal-title":"Hum Reprod Update"},{"key":"10.1136\/ard.2011.153817_bib20","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1136\/ard.2011.153817_bib21","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.109.904235","article-title":"Health effects of light and intermittent smoking: a review","volume":"121","author":"Schane","year":"2010","journal-title":"Circulation"},{"key":"10.1136\/ard.2011.153817_bib22","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case\u2013control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1136\/ard.2011.153817_bib23","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2011.153817_bib24","series-title":"Case\u2013control studies. Design, conduct, analysis","author":"Schlesselman","year":"1982"},{"key":"10.1136\/ard.2011.153817_bib25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2011.153817_bib26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-2006-951298","article-title":"Inherited thrombophilia and venous thromboembolism","volume":"32","author":"Simioni","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1136\/ard.2011.153817_bib27","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1136\/ard.2011.153817_bib28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/ard.2010.142042","article-title":"Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study","volume":"70","author":"Ruffatti","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2011.153817_bib29","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.fertnstert.2010.02.032","article-title":"Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome","volume":"94","author":"Mart\u00ednez-Zamora","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1136\/ard.2011.153817_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/bmj.326.7386.423","article-title":"Spontaneous loss of early pregnancy and risk of ischaemic heart disease in later life: retrospective cohort study","volume":"326","author":"Smith","year":"2003","journal-title":"BMJ"},{"key":"10.1136\/ard.2011.153817_bib31","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2011.153817_bib32","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3899\/jrheum.081194","article-title":"Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus","volume":"36","author":"Danowski","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2011.153817_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0961203307084724","article-title":"Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients","volume":"17","author":"Hereng","year":"2008","journal-title":"Lupus"},{"key":"10.1136\/ard.2011.153817_bib34","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0140-6736(00)05112-6","article-title":"Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births","volume":"357","author":"Smith","year":"2001","journal-title":"Lancet"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724190164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724190164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2011.153817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:07:07Z","timestamp":1737248827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724190164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0003496724190164"],"URL":"https:\/\/doi.org\/10.1136\/ard.2011.153817","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2011.153817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}